While tuberculosis (TB) may be perceived as a malady relegated to the past, it continues to loom as a global health concern. The rise of antibiotic-resistant TB, despite significant strides in diagnosis and treatment, presents a growing menace. This phenomenon not only jeopardizes public health on a global scale but also undermines the progress achieved in disease control over the years. This article will delve into the intricate interplay between tuberculosis and antibiotic resistance, exploring the root causes and the consequential effects of this pressing issue.
https://www.broadinstitute.org/visuals/infographic-tb-and-antibiotic-resistance
The Fundamentals of Tuberculosis
Mycobacterium tuberculosis is the causative agent of the infectious illness tuberculosis. A potentially fatal condition if left untreated, it predominantly targets the lungs but can also target other organs. When a person with TB coughs or sneezes, the disease spreads via the air and is very contagious. As evidenced by the discovery of TB in Egyptian mummies, it has long been recognized as a human disease.
The Introduction of Antibiotics
The development of antibiotics in the 20th century, particularly streptomycin and isoniazid, revolutionized the management of tuberculosis. For the first time, medicine could successfully treat TB. This new breakthrough raises hopes that the illness could be cured.
Antibiotic Resistance: A Problem
Antibiotic-resistant TB strains were unavoidably developing as antibiotics took over as the primary method of TB treatment. When bacteria, in this case Mycobacterium tuberculosis, evolve genetic modifications that enable them to withstand antibiotic exposure, antibiotic resistance emerges. These resistant strains increase in frequency over time.
https://www.sciencedirect.com/science/article/pii/S1471489217301571
Types of TB that Resists Antibiotics
Antibiotic-resistant tuberculosis primarily comes in two forms:
1- Multi-Drug-Resistant TB (MDR-TB)- Isoniazid and rifampicin, the two most potent first-line medications, are not effective against multi-drug-resistant tuberculosis. Treatment for MDR-TB is far more difficult, needing more toxic medications for longer periods of time.
2- Extensively Drug-Resistant Tuberculosis (XDR-TB): XDR-TB is much more worrisome because it is resistant to important second-line medications in addition to first-line medications. As a result, there are fewer treatment alternatives and better chances of success available to healthcare practitioners.
Effects of TB with antibiotic resistance
TB that is resistant to antibiotics has serious effects on both human health and public health:
- Reduced Treatment Effectiveness: Treating resistant TB is more difficult, expensive, and time-consuming. Lower success rates result in more deaths.
- Increased Transmission: Drug-resistant TB cases can increase as a result of resistant strains spreading within communities.
- Global concern: TB has no regard for national boundaries and is a concern to all nations due to the ease with which drug-resistant strains can spread.
- Economic Impact: TB has a significant negative impact on the economy, particularly when it is drug-resistant, as a result of higher treatment costs and reduced productivity.
Conclusion
Urgent and immediate attention must be directed towards the critical nexus between antibiotic resistance and tuberculosis. While new medications and therapeutic approaches are in development, the emphasis on prevention remains paramount. This involves ensuring that individuals with TB receive optimal care and advocating for judicious use of antibiotics across all medical scenarios. Only through collaborative global efforts can we hope to curb this escalating threat and make substantial strides towards eradicating TB as a significant global health concern.
Resources: